IPRIVASK (DESIRUDIN RECOMBINANT) — FDA Approval BLA021271 (BAUSCH)
IPRIVASK (DESIRUDIN RECOMBINANT) — FDA Approval BLA021271 (BAUSCH) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: IPRIVASK; Active ingredients: DESIRUDIN RECOMBINANT; Application number: BLA021271.
| Brand name | IPRIVASK |
|---|---|
| Active ingredients | DESIRUDIN RECOMBINANT |
| Application number | BLA021271 |
| Sponsor | BAUSCH |
| Dosage form | INJECTABLE |
| Route | SUBCUTANEOUS |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 20030404 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →